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Laryngeal cancer is more common in males. The present study is aimed at exploration of potential of conventional Raman
spectroscopy in classifying normal from a malignant laryngopharyngeal tissue. We have recorded Raman spectra of twenty tissues
(aryepiglottic fold) using an in-house built Raman setup. The spectral features of mean malignant spectrum suggests abundance
proteins whereas spectral features of mean normal spectrum indicate redundancy of lipids. PCA was employed as discriminating
algorithm. Both, unsupervised and supervised modes of analysis as well as match/mismatch “limit test” methodology yielded
clear classiﬁcation among tissue types. The ﬁndings of this study demonstrate the eﬃcacy of conventional Raman spectroscopy
in classiﬁcation of normal and malignant laryngopharyngeal tissues. A rigorous evaluation of the models with development of
suitable ﬁbreoptic probe may enable real-time Raman spectroscopic diagnosis of laryngopharyngeal cancers in future.
1.Introduction
“Hypopharyngeal,” also known as “laryngopharyngeal,” can-
cers are tumors of a subsite of the upper aerodigestive
tract within the group of head and neck malignancies. The
hypopharynx is the region between the oropharynx and the
esophageal inlet. Approximately 7% of all cancers of the
upper aerodigestive tract are of hypopharyngeal origin [1].
Incidence of these cancers seems to be four to ﬁve times
less common compared to laryngeal cancers. All pharyngeal
subsites accounted for approximately 1,24,000 cancer cases
worldwide in 2002 [1]. India has the second largest popu-
lation in the world with predominant oral, pharyngeal, and
oesophageal cancers among females and laryngeal cancers
among males [2, 3]. This is attributed to intake of various
tobacco products like “paan.” Smoked tobacco and slaked
lime in paan are said to have synergistic carcinogenic
eﬀect in the upper aerodigestive tract [4]. Hypopharyngeal
cancers are usually squamous cell carcinomas (SCCs) and
are notorious as they usually present in advanced primary
disease with or without nodal metastasis. The reconstruction
after wide surgical resection in such cases is challenging and
may increase morbidity and mortality. Hence early diagnosis
is essential. A Contrast-enhanced computed tomography
(CT) or a magnetic resonance imaging (MRI) of the head
and neck is the mainstay initial radiological evaluation of
these cancers [5]. PET scan is the latest imaging technique
emerged to detect residual, recurrent tumors or secondaries.
Due to occasional false positive results in cases of active
inﬂammation or infection, this technique is also eventually
dependant on biopsy for conﬁrmation. Presently, rigid
endoscopy and biopsy as mandatory as histopathology is
the current gold standard for tissue diagnosis. The clinicians
are dependant on skilled pathologist for accurate diagnosis.
Moreover,thetissuesamplemaybeinadequateorthepathol-
ogist may request deeper “repeat” multiple tissue biopsy.
In anticipation of the biopsy report, patient may lose three
to four days before active intervention of treatment. Only
the gross manifestation of tissue changes arouse suspicion
making assessment by hypopharyngoscopy under general2 Pathology Research International
anaesthesia mandatory. This subjects the patient to possi-
bility of excess bleeding or anaesthesia-related complications
especially in elderly patients and/or postoperative pain while
swallowing. The tissue biopsy is especially challenging in
irradiated cases wherein frank growth (residual or recurrent)
may be obscured due to induration or Edema. The other
modalities of tissue diagnosis may be particularly necessary
as conﬁrmation in false positive interpretation [6]o fm a l i g -
nancies.Hence,itiscrucialtodependonalternativemethods
to (1) conﬁrm malignancy, (2) detect latent or early mitotic
changes before gross appearance of abnormal tissue, and (3)
extend its application to in vivo or in situ conditions.
Optical spectroscopic methods such as autoﬂuorescence
[7–9], Fourier transform infrared (FTIR) [10, 11], and
Raman [12] have been the other methods of detection of
malignancies. These optical methods attribute noninvasive-
ness unlike a painful biopsy with no prerequisite for staining
or sample preprocessing. All are amenable to multivariate
statistical tools for easy analysis.
Among the above-mentioned optical methods, ﬂuores-
cence and FTIR are more popular due to simple instru-
mentation. Raman spectroscopy oﬀers distinct advantages
compared to other popular optical techniques. This is
because less harmful near-infrared radiation is used for
excitation with easy extraction of information due to distinct
and sharp spectral features. The water content in tissues may
not deter precision in diagnosis for in vivo and in situ future
applications.
The shortcoming of ﬂuorescence technique is that it may
require an experienced ENT specialist to detect laryngeal
cancer in vivo and it has had low speciﬁcity in tissue
diagnosis. The method of diagnosis by contact endoscopy
for preoperative screening of laryngeal malignancy also has
limitation in its application. It allows assessment of only the
superﬁcial layers of epithelium [13].
The mode of diagnosis by tissue analysis using Raman
spectroscopyhasbeenprovedtobeausefultoolinclassifying
oral [14–17], brain [18], breast [19–21], cervical [22, 23],
ovarian [24], nasopharyngeal [25], laryngeal [26–28], gas-
trointestinal tract [29–33], and skin [34] malignancies.
There are only three series of laryngeal and one study
of nasopharyngeal cancers reported [25–28]s of a r .T h e
signiﬁcance of diagnosing hypopharyngeal cancers early
is evident by the fact that these present worst prognosis
especially because most of them present in advanced stages.
With application of lasers in head and neck surgeries, a
precise and optimum excision of a localized hypopharyngeal
lesion is possible with good long-term prognosis. This
highlights emphasis on early detection of hypopharyngeal
tissue malignancy. Raman spectroscopy methodologies are
ideal tools for noninvasive screening of population due to
it’s suitability for in situ and in vivo measurements. Since
no spectroscopy study of hypopharyngeal cancers has been
reported in the literature to date, we have carried out an
exploratory conventional ex vivo Raman spectroscopy study
of hypopharyngeal squamous cell carcinoma. We found
that conventional Raman spectroscopy, unlike microscopy,
p r o b e sl a r g e ra r e a st h u sp r o v i d e sr e p r e s e n t a t i v es p e c t r a .
Conventional Raman studies of ex vivo tissues have been an
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Figure 1: Pictorial presentation of gross laryngeal specimen after
excision showing marginal zone formed by the upper margin of
the aryepiglottic fold (AEF). The right AEF (big spot) showing
ulceroproliferative growth and left AEF (small spot) that appears
normal are indicated.
exploratory approach before the eventual in vivo applica-
tions.Inthisexploratorystudy,patientswithhistopathologic
evidence malignancy involving the free border of aryepiglot-
tic fold were selected and compared with the other normal
subsite. The ﬁndings of the study are discussed in the present
paper.
2.MaterialsandMethods
In total, twenty tissue samples were studied comparing the
malignant tissue site with the corresponding normal site
in each patient from January 2007 to December 2007. Ten
patients with age range 43 years to 75 years and male to
female ratio of 9:1 were considered for biopsy. Patients with
unilateral marginal zone or the aryepiglottic fold malignancy
were chosen because it is a transition area from laryngeal
mucosa to hypopharyngeal mucosa. This is also known
as “laryngopharynx” and is representative of the upper
aerodigestive tract histologically. The marginal zone on the
other side was grossly free of lesion as it appeared as soft and
supple tissue. This study was approved for one year by the
Manipal University Ethical Clearance Committee.
The biopsy specimens were taken from the growth and
the corresponding normal side (Figure 1) .T h e s ew e r ep u t
in individual saline bottles and delivered to the laser spec-
troscopy department. All the specimens were snap frozen
in liquid nitrogen and passively thawed before subjected to
Raman studies. A total of twenty samples were subjected to
this study. A mirror image of all biopsy specimens were also
sent for conﬁrmative histopathology. Histopathologically,
the ten malignant specimens were diagnosed to be squamous
cell carcinoma (six patients had moderately diﬀerentiated
while two patients each had inﬁltrating type and poorly
diﬀerentiated carcinoma).
3. Laser Raman Spectroscopy
Raman spectra were recorded using the setup which was
assembled by us [14, 15, 20, 22, 24, 31, 33]. In brief, thisPathology Research International 3
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Figure 2: Schematic of the Raman instrumentation.
instrumentation employed diode laser (SDL-8530 785nm,
100mW)forexcitationandHR320spectrograph(600g/mm
blazed at 900nm) and spectrum one liquid N2-cooled
CCD for dispersion and detection of Raman signals. The
Rayleigh scattering was ﬁltered out using holographic ﬁlter
(HSBF-785.0; Kaiser Optics). A schematic of the Raman
instrumentation is presented in Figure 2. More than six
spectra were recorded in each tissue. Each spectrum was
acquired for 30 seconds and averaged over 20 accumulations.
These experimental settings were kept constant during the
study. Samples were kept moist in saline during spectral
acquisition. The recorded spectra were postcalibrated with a
cubic ﬁt to known frequencies of Tylenol.
4.DataAnalysis
The spectra were baseline corrected, smoothened, calibrated
using diode adjust algorithms in Grams 32 (Galactic Indus-
tries corporation, USA) [35] and normalized over δCH2
band. The preprocessed spectra were then subjected to
Principle Component Analysis (PCA), a known data reduc-
tion technique where huge spectral data are decomposed
into small independent variables known as “factors” and
contributions of these factors were called “scores.” Spectral
data Analysis was carried out over entire region as well
as several selected short regions besides derivatives of the
same regions for standardization purposes. Total percentage
variance, eigenvalues, and factor proﬁles were employed for
standardization of PCA. Trail runs were carried out using
20, 15, 12, and 9 factors. In our analysis spectral range of
900–1750cm−1 with 9 factors gave optimum results. Further
dataanalysiswascarriedoutundertheseconditions.Analysis
was carried out in unsupervised and supervised modes. In
the unsupervised approach, scores of factor were used as
discriminating parameter whereas, in the supervised mode,
Mahalanobis Distance and spectral residuals were used as
discriminating parameters [35, 36]. We have also explored
match/mismatch “limit test” approach which is known to
bringoutobjectiveandunambiguousdiscrimination[14,15,
20,22,24,31,33].Theﬂowchartofthestudydesignisshown
in Figure 3.
5. Results and Discussion
Mean Raman spectra of normal and malignant hypopha-
ryngeal tissues are shown in Figure 4. On cursory exam-
ination, mean normal spectrum exhibits weak 1650cm−1,
δCH2 band at around 1445cm−1, sharp peaks at 1304
and 1277cm−1, and a broad peak at 1085cm−1. These
spectral features indicate abundance of lipids in normal
hypopharyngeal tissues. On the other hand, mean malignant
spectrum, distinguished by broad and strong amide I at
around 1655cm−1, red shifted δCH2 at around 1449cm−1,
broad amide III, and sharp peak at 1004cm−1 suggest
increased protein content with respect to normal tissues.
We have observed similar features of abundance of lipids
and proteins in normal and malignant oral tissue spectra,
respectively [14–17].
For better correlation of spectral and biochemistry, the
diﬀerence spectrum was computed by subtracting mean
normal spectrum from mean malignant spectrum as shown
in Figure 5. All the negative peaks (917, 983, 1072, 1302,
1440cm−1)s e e ni nFigure 5 were contributed by normal
spectrum attributable to lipids whereas all positive peaks
(949, 1004, 1127, 1238, 1340, 1643cm−1)w e r ef r o mm a l i g -
nant spectrum which could be assigned to proteins. Besides
highproteincontent,spectralfeaturesofthemeanmalignant
tissue spectrum also indicate the presence of additional
biomolecules like DNA (1340cm−1) and variations in sec-
ondary structure of the protein as indicated by amide I and
III bands [37, 38]. We have also veriﬁed heterogeneity of
spectra among same class of tissues, for example, normal
and malignant tissues, by computing mean and standard
deviationofnormalaswellasmalignantspectraasillustrated
in Figure 6.I nFigure 6, the mean and standard deviation
spectra indicate very minor heterogeneity and minor inten-
sity diﬀerences.
It is well known that there are several multivariate
statistical methods available for the spectroscopist for data
mining. We have opted PCA for spectral data analysis in
order to discriminate malignant from normal tissue types.
In our method of PCA, the mean of all samples in the data
s e ti sﬁ r s tf o r m e d .T h ed i ﬀerences of this mean from each
sample are calculated to give the variations of each sample4 Pathology Research International
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Figure 4: Mean spectra of (a) normal and (b) malignant hypopha-
ryngeal tissues.
from the mean. With n samples, each having p data points,
we thus get an [n × p] matrix of these variations. Because
all the samples contain more or less the same components
(e.g., lipids, proteins, and collagen) the large amount of data
can be represented by a much smaller set of components
and their contributions to each spectrum depending on their
concentrations. In matrix language this implies that the [n ×
p] matrix of variations discussed above is highly redundant.
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Figure 5: Diﬀerence spectrum of mean malignant minus mean
normal spectrum.
It will have only a few eigenvectors (principal components),
and the eigenvalues of these will rapidly come down to
almost zero after the ﬁrst few. Solving the eigen value-
eigen vector problem will give us the principal components
(factors), % variance (contribution of the factors to the
variations in the data set), and scores of factors for each
sample. The scores for a given sample correspond to the
contribution of each principal component to the variation
of that sample from the mean. It is therefore possible to
simulatetheobservedspectrumofanysamplebymultiplying
the eigen vectors with their respective scores for that sample
and adding these products to the mean of the data set.
As described above, in PCA large amount of spectral data
is expressed by independent variables called eigenvectors,
factors, or principal components and their scaling constants,Pathology Research International 5
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Figure 6: Mean and standard deviation spectra of hypopharyngeal
tissues. (a) Normal. (b) Malignant.
s c o r e s .S c o r e so ff a c t o r sa r eo f t e nu s e da sp a r a m e t e r s
to achieve objective discrimination. As mentioned earlier
in Section 4, analysis was carried out in two diﬀerent
approaches: (1) unsupervised analysis, (2) supervised anal-
ysis. We have successfully tested these approaches in our
earlier Raman spectroscopic studies of cervix, oral, and
breast cancers [14, 15, 20, 22, 24, 31, 33].
In the ﬁrst approach a total of 108 spectra from normal
and malignant hypopharyngeal tissue were ascertained for
unsupervised classiﬁcation. Proﬁles of the factor loadings
are shown in Figure 7. The ﬁrst ﬁve factors contribute 94%
of variance, and the last two account for noise. There is
clustering of normal and malignant spectra based on score
of factor 1, as shown in Figure 8. The scores of factor 1 for
normal spectra were generally positive for malignant and
negative for normal tissues with a mean standard deviation
of 0.011 ± 0.05 and − 0.06 ± 0.03, respectively. Mean and
standard deviation values of normal and malignant spectra
of score of factor 2 were 0.02 ± 0.05 and − 0.01 ± 0.12. A
minor overlap is present between clusters up to ±1 standard
deviation, which indicates a sensitivity and speciﬁcity of
75%.
Analysis by score of factors may give a clear classiﬁcation
oftissuesfordiscrimination;howeverthisapproachofclassi-
ﬁcation is somewhat cumbersome and tedious because diag-
nosis of a sample needs entire analysis to be repeated along
with new spectra. Moreover, it may be of limited practical
utility for the end-users, clinicians, since a visual decision-
making is involved in the case of borderline samples. In view
of these considerations, we have developed a second method
using multiple discriminating parameters to give a better
and objective diagnosis. For this, like in any analytical tech-
nique where standards with calibration curves are used for
routine analysis, spectra of a set of clinically/pathologically
diagnosed samples can be used as a standard calibration set.
This standard calibration set can be subjected to PCA to
derive parameters which will be highly characteristic for any
sample of that type. Any test sample can then be included in
the set, and the corresponding parameters for the test sample
canbecomparedtothemeanparametersforthesettodecide
whether the test sample belongs to that set and, if so, with
what statistical probability. We have thus several statistical
parameters available for decision-making in PCA, especially
when standard calibration sets are used. In this mode
besides scores of factor, PCA provides other discriminating
parameters of classiﬁcation such as Mahalanobis distance
[35, 36] (a measure of proximity of two spectra) and spectral
residuals (squared error sum of diﬀerence between recorded
and simulated spectrum). Hence the supervised mode which
provides multiple discriminating parameters is better suited
for objective diagnosis by spectroscopy methods, especially
for clinical conditions. In this analysis certain certiﬁed
samples were used to develop standard sets. A given spectra
was compared with these sets to decide whether it belongs to
the standard set with the statistical probability of inclusion.
If Mahalanobis distance of the test spectra has values more
than three, compared to the training sets it had a probability
of 0.5% or less of being grouped as the same class. The
Mahalanobis distance [35] is normally expressed in units of
standard deviation and expressed as
D2 = (Stest)M
−1(Stest) . (1)
In the previous equation, Stest is the vector of the scores and
the sum of squared spectral residuals for a given test sample,
where
M = S S/(n −1). (2)
“S” contains the corresponding parameters for the calibra-
tion set (n standards).
In our study, we have selected 25 normal and 28
malignant spectra randomly based on a score of factor
1 and histopathological certiﬁcation. The consistency of
the standard sets was veriﬁed by rotating spectra from
training sets and comparing them against both training sets.
The spectra corresponding to same class of training sets
procure lower Mahalanobis distance and spectral residues
and vice versa. As an example, results obtained against
a malignant training set were shown in Figure 9(a).T h e
meanMahalanobisdistanceofnormalandmalignantspectra
were 15.1 ± 8.13 and 0.93 ± 0.61, respectively. The mean
spectral residual values for normal and malignant tissues
were 48.11 ± 24.23 and 3.52 ± 2.99, respectively.
These standard sets were further evaluated by spectra
that were not involved in training sets wherein the test
spectra were compared against both the training sets. A
good discrimination was achieved, for example, as shown in
Figure 9(b) of results obtained against the normal training
set. The mean Mahalanobis distance of normal and malig-6 Pathology Research International
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nant were 3.37 ±2.47 and 32.05 ± 12.8, respectively.
The approach of computing mahalanobis distance and
spectral residuals is further extended to multiparametric
“limittest”approachinordertoachieveobjectiveandunam-
biguous discrimination. This is a typical match/mismatch
approach against a standard set. A given spectra was
compared with ﬁxed values of inclusion/exclusion criteria
for analysis of Mahalanobis distance, spectral residuals, and
scores of factors. Based on these values of a given spectrum
being within or without the set limits, the spectrum was
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Table 1: Limit test approach against normal standard set (1–48
normal, 49–108 malignant).
Sample Number Match Limit test
1 POSSIBLE PASS (PP?#)
2 POSSIBLE PASS (PP?#)
3 YES PASS (PPP#)
4 YES PASS (PPP#)
5 YES PASS (PPP#)
6 POSSIBLE PASS (PP?#)
7 YES PASS (PPP#)
8 YES PASS (PPP#)
9 YES PASS (PPP#)
10 YES PASS (PPP#)
11 YES PASS (PPP#)
12 YES PASS (PPP#)
13 POSSIBLE PASS (PP?#)
14 POSSIBLE PASS (PP?#)
15 YES PASS (PPP#)
16 YES PASS (PPP#)
17 YES PASS (PPP#)
18 POSSIBLE PASS (PP?#)
19 YES PASS (PPP#)
20 YES PASS (PPP#)
21 YES PASS (PPP#)
22 YES PASS (PPP#)
23 POSSIBLE PASS (PP?#)
24 YES PASS (PPP#)
25 POSSIBLE PASS (PP?#)
26 YES PASS (PPP#)
27 POSSIBLE PASS (PP?#)
28 YES PASS (PPP#)
29 POSSIBLE PASS (PP?#)
30 YES PASS (PPP#)
31 YES PASS (PPP#)
32 POSSIBLE PASS (PP?#)
33 YES PASS (PPP#)
34 YES PASS (PPP#)
35 YES PASS (PPP#)
36 YES PASS (PPP#)
37 YES PASS (PPP#)
38 YES PASS (PPP#)
39 POSSIBLE PASS (PP?#)
40 POSSIBLE PASS (PP?#)
41 YES PASS (PPP#)
42 POSSIBLE PASS (PP?#)
43 YES PASS (PPP#)
44 YES PASS (PPP#)
45 YES PASS (PPP#)
46 YES PASS (PPP#)
47 POSSIBLE PASS (PP?#)
48 POSSIBLE PASS (PP?#)
Table 1: Continued.
Sample Number Match Limit test
49 NO FAIL (FFF#)
50 NO FAIL (FFF#)
51 NO FAIL (FFF#)
52 NO FAIL (FFF#)
53 NO FAIL (FFF#)
54 NO FAIL (FFF#)
55 NO FAIL (FFF#)
56 NO FAIL (FFF#)
57 NO FAIL (FFF#)
58 NO FAIL (FFF#)
59 NO FAIL (FFF#)
60 NO FAIL (FFF#)
61 NO FAIL (FFF#)
62 NO FAIL (FFF#)
63 NO FAIL (FFF#)
64 NO FAIL (FFF#)
65 NO FAIL (FFF#)
66 NO FAIL (FFF#)
67 NO FAIL (FFF#)
68 NO FAIL (FFF#)
69 NO FAIL (FFF#)
70 NO FAIL (FFF#)
71 NO FAIL (FFF#)
72 NO FAIL (FFF#)
73 NO FAIL (FFF#)
74 NO FAIL (F?F#)
75 NO FAIL (FFF#)
76 NO FAIL (FFF#)
77 NO FAIL (FFF#)
78 NO FAIL (FFF#)
79 NO FAIL (FFF#)
80 NO FAIL (PFF#)
81 NO FAIL (PFF#)
82 NO FAIL (FFF#)
83 NO FAIL (FFF#)
84 NO FAIL (FFF#)
85 NO FAIL (FFF#)
86 NO FAIL (FFF#)
87 NO FAIL (F?F#)
88 NO FAIL (FFF#)
89 NO FAIL (FFF#)
90 NO FAIL (FFF#)
91 NO FAIL (P?F#)
92 NO FAIL (P?F#)
93 NO FAIL (FFF#)
94 NO FAIL (FFF#)
95 NO FAIL (FFF#)
96 NO FAIL (FFF#)
97 NO FAIL (FFF#)8 Pathology Research International
Table 1: Continued.
Sample Number Match Limit test
98 NO FAIL (F?F#)
99 NO FAIL (FFF#)
100 NO FAIL (FFF#)
101 NO FAIL (FFF#)
102 NO FAIL (FFF#)
103 NO FAIL (FFF#)
104 NO FAIL (FFF#)
105 NO FAIL (FFF#)
106 NO FAIL (FFF#)
107 NO FAIL (PFF#)
108 NO FAIL (FFF#)
labeled as “Yes/possible/pass (match)” or “No/fail (mis-
match)”respectively.Inthisanalysis,asanexample,anormal
spectrum should show “Yes/possible/pass” when compared
to a normal standard set and “No/fail” with other standard
sets and vice versa. Since the spectra are matched against all
the standard sets, a reasonable and objective discrimination
is achieved before concluding the type of the tissue. All
malignant and nonmalignant spectra show “match” and
“no match”, respectively, when compared with a malignant
standardset(Table 1).Inthistable,spectra1–48werenormal
tissue spectra, and spectra 49–108 were of malignant tissues.
Eﬃcacy of this approach was demonstrated in our earlier
Raman studies of oral, breast, cervix, stomach, and colon
cancers [14, 15, 20, 22, 24, 31, 33].
The results obtained in this pilot study provide reli-
able evidence on Raman spectroscopic discrimination of
malignant hypopharyngeal tissues from normal. The limit
test approach is signiﬁcant in early clinical diagnosis as a
clinician or technician can match a recorded spectrum with
the training sets once they are developed for diﬀerent patho-
logical conditions aiding easy objective decisions, which is
the ground stone for attempting curative treatment plan.
The future lies in designing a ﬁbre probe tissue interface
obtaining calibrated intensity information and depth rang-
inginformation.Ramanprobesmaybedesignedtoeliminate
scattering distortion while providing the endoscopic images
ofthechemicaland/ormorphologicalpropertiesofthetissue
to complement tissue diagnosis on immediate basis during
surgery or a diagnostic procedure.
6. Conclusion
Tobacco chewing and smoking is rampant and hazardous in
an already rapidly increasing population. This doubles the
need and eﬀort to make early, easy, and immediate detection
ofmalignant changes of the abusedand vulnerablehypopha-
ryngeal tissues. Though there are various methods to detect
cancerous tissue, each has a drawback that may be overcome
by expanded study of an alternative modality of tissue
diagnosissuchasconventionalRamanspectroscopy.Spectral
signatures were characterized by variations in the protein
and lipid content at biomolecular level. Discriminating
parameters scores of factor, Mahalanobis distance, spectral
residuals provided clear classiﬁcation between normal and
malignant tissue types. Further the “limit test” approach
also provided unambiguous and objective discrimination,
which is more user-friendly and adaptable to routine clinical
practice as it requires a minimally trained person and even
a clinician and technician can come to a conclusion before
taking a decision.
However, a conﬁrmed application of Raman spec-
troscopy technique will come to force following prolonged
prospective study and introducing endoscopy friendly
Raman probes.
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